Student model architecture. by Ahmed Akib Jawad Karim (20427740)

“…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”

Configuration of the LastBERT model. by Ahmed Akib Jawad Karim (20427740)

“…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”

Confusion matrix for DistilBERT model. by Ahmed Akib Jawad Karim (20427740)

“…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”

ROC curve for LastBERT model. by Ahmed Akib Jawad Karim (20427740)

“…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”

Sample Posts from the ADHD dataset. by Ahmed Akib Jawad Karim (20427740)

“…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”

Top-level overview for ADHD classification study. by Ahmed Akib Jawad Karim (20427740)

“…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”

Clinical characteristics of ALS patients. by Aude-Marie Grapperon (20598142)

“…<div><p>Objective</p><p>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by significant heterogeneity among patients. …”

Progression of mean clinical scores (d.c.s. and g.c.s.). by Llum Páez (22553360)

Subjects:

Sociodemographic and clinical characteristics of all participants recruited for this study. by Inés Armenteros-Yeguas (22530130)

Clinical and demographic data of the participants enrolled in this study. by Francois Dao (8521683)

Subjects:

Socio-demographic and clinical characteristics of participants. by Casmir E. Amadi (14271257)

DEGs and enrichment analysis in HepG2 cells expressing HBx. by Jianhua Zhong (11351726)

ASP protects the AC16 cells from DOX-induced cardiotoxicity via Nrf2 activation. by Xueyang Bai (20550422)

“…<p>(A) Representative images of protein expression detected by Western blot of p-PI3K,p-AKT, AKT, and the Nrf2 downstream signaling pathways in AC16 cells; (B, C) ML385 does not affect PI3K/AKT (n = 3); (D-F) The statistical results show that ML385 significantly represses NRF2 activation, leading to a decrease in its downstream gene expression (n = 3); (G, H) Lipid ROS levels (n = 3); (I, J) Quantitative q-PCR analysis of relative ANP and BNP mRNA expression (n = 3); (K, L) Representative images (Scale bar =  100 μm) and statistical analysis of JC-1 (n = 150); One-way ANOVA (Tukey post-test), means ±  SD. …”

The results of mediating mechanism test. by Le Zhu (1771669)

Subjects:

Balance test results. by Le Zhu (1771669)

Subjects:

Variables. by Le Zhu (1771669)

Subjects:

Results of the parallel trend test. by Le Zhu (1771669)

Subjects:

Results of the exclusion of other policies. by Le Zhu (1771669)

Subjects:

Results of robustness tests. by Le Zhu (1771669)

Subjects:

Descriptive statistical of variables. by Le Zhu (1771669)

Subjects: